Raymond James Financial Services Advisors’s Bio-Path Holdings Inc BPTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-36
Closed -$2K 2883
2018
Q4
$2K Sell
36
-1
-3% -$172 ﹤0.01% 2561
2018
Q3
$9K Hold
37
﹤0.01% 2792
2018
Q2
$22K Hold
37
﹤0.01% 2722
2018
Q1
$30K Hold
37
﹤0.01% 2471
2017
Q4
$30K Buy
37
+1
+3% +$1.29K ﹤0.01% 2467
2017
Q3
$51K Sell
36
-1
-3% -$1.37K ﹤0.01% 2452
2017
Q2
$57K Sell
37
-156
-81% -$327K ﹤0.01% 2402
2017
Q1
$640K Hold
193
﹤0.01% 1443
2016
Q4
$1.04M Sell
193
-300
-61% -$1.45M 0.01% 1090
2016
Q3
$2.76M Buy
493
+489
+12,225% +$3.14M 0.02% 627
2016
Q2
$28K Hold
4
﹤0.01% 2203
2016
Q1
$37K Buy
+4
New +$25.9K ﹤0.01% 1986

Other funds holding BPTH

Raymond James Financial Services Advisors's BPTH Position: Q1 2019 in Review

Raymond James Financial Services Advisors sold out of Bio-Path Holdings Inc (BPTH) in Q1 2019, closing a stake of 36 shares — an estimated $2K sold.

Raymond James Financial Services Advisors first reported a position in BPTH in Q1 2016 and held it in 12 quarters. The position peaked at $2.76M in Q3 2016. 18 funds tracked by Wall St. Rank hold BPTH as of Q1 2019.

  • Raymond James Financial Services Advisors reported no remaining Bio-Path Holdings Inc position as of Q1 2019 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 36 Bio-Path Holdings Inc shares in Q1 2019, an estimated $2K.
  • Raymond James Financial Services Advisors first reported a position in Bio-Path Holdings Inc in Q1 2016 and held it in 12 quarters.
  • Raymond James Financial Services Advisors's Bio-Path Holdings Inc position peaked at $2.76M in Q3 2016.
  • 18 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2019.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2019, filed 6 May 2019.